UCBJY - UCB SA

Other OTC - Other OTC Delayed Price. Currency in USD
37.39
+1.55 (+4.32%)
At close: 1:32PM EST
Stock chart is not supported by your current browser
Previous Close35.84
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume32
Market Cap14.891B
Beta0.42
PE Ratio (TTM)18.29
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.63 (1.75%)
Ex-Dividend Date2017-04-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Regulus Therapeutics (RGLS) Looks Good: Stock Adds 5.6% in Session
    Zacks2 months ago

    Regulus Therapeutics (RGLS) Looks Good: Stock Adds 5.6% in Session

    Regulus Therapeutics Inc. (RGLS) was a big mover last session, as the company saw its shares rise nearly 6% on the day amid huge volumes

  • UCB SA :UCBJY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017
    Capital Cube4 months ago

    UCB SA :UCBJY-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis UCB SA reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of UCB SA – Amgen Inc., Biogen Inc. and Novartis AG Sponsored ADR (AMGN-US, BIIB-US and NVS-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more (Read more...)

  • TheStreet.com7 months ago

    UCB Stock Plunges After Trials Reveal Safety Risk in Amgen JV

    UCB stock plummeted Monday after clinical trials shone a light over a possible safety risk related to the Osteoporosis treatment that it has been developing alongside Amgen

  • UCB SA : UCBJY-US: Dividend Analysis : May 02nd, 2017 (record date) : By the numbers : April 28, 2017
    Capital Cube7 months ago

    UCB SA : UCBJY-US: Dividend Analysis : May 02nd, 2017 (record date) : By the numbers : April 28, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing UCB SA with the following peers – Amgen Inc., Shire PLC Sponsored ADR, Pfizer Inc., Biogen Inc., Novartis AG Sponsored ADR and Catalyst Pharmaceuticals, Inc. (AMGN-US, SHPG-US, PFE-US, BIIB-US, NVS-US and CPRX-US). UCB SA’s dividend yield is 1.03 percent and its dividend payout is 24.00 ... Read more (Read more...)

  • UCB SA :UCBJY-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017
    Capital Cube9 months ago

    UCB SA :UCBJY-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017

    Categories: Yahoo Finance Get free summary analysis UCB SA reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of UCB SA – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc. and Novartis AG Sponsored ADR (SHPG-US, AMGN-US, PFE-US, BIIB-US and NVS-US) that have also reported for ... Read more (Read more...)

  • UCB SA :UCBJY-US: Earnings Analysis: For the six months ended December 31, 2016 : February 28, 2017
    Capital Cube9 months ago

    UCB SA :UCBJY-US: Earnings Analysis: For the six months ended December 31, 2016 : February 28, 2017

    Categories: Yahoo Finance Get free summary analysis UCB SA reports financial results for the half-year ended December 31, 2016. We analyze the earnings along side the following peers of UCB SA – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc. and Novartis AG Sponsored ADR (SHPG-US, AMGN-US, PFE-US, BIIB-US and NVS-US) that have also reported for ... Read more (Read more...)